Federally Funded Survey of 65 Cancer Patients Finds Reported Cannabis Benefits but Cost and Stigma Barriers
A federally supported study analyzed open-ended online survey responses from 65 adults with cancer who self-reported using cannabis therapeutically. Participants reported perceived benefits including pain relief, better sleep, physical relaxation, emotional regulation, and reduced use of other medication; stigma around THC and high product costs were the most frequently reported barriers. The authors called for insurance coverage to reduce patients’ financial burden. This was a self-selected, self-report qualitative network analysis, not a randomized efficacy trial: products were not laboratory-verified, there was no non-cannabis control group, and the findings cannot establish causation or medical advice.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
marijuanamoment.net
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://www.marijuanamoment.net/federally-funded-cancer-study-highlights-need-to-cover-medical-marijuana-under-insurance-researchers-say/